Skip to main content
HairCited

研究プロセス

150 査読済み研究からの図表

すべて セレン ケラチン コラーゲン ミノキシジル デュタステリド フィナステリド スピロノラクトン ローズマリーオイル マイクロニードリング オメガ3脂肪酸 ビタミンB12 ビタミンD L-システイン MSM PRP療法 亜鉛 低出力レーザー治療 カフェイン（外用） 鉄
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 15
Figure 15 Chart

Hematological parameters in diazinon-exposed rats with and without plant oil supplementation, reflecting systemic toxicity effects.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 16
Figure 16 Chart

Cholinesterase activity levels in rats treated with diazinon and plant oils, as diazinon is an organophosphate that inhibits acetylcholinesterase.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 17
Figure 17 Chart

Additional biochemical markers in the diazinon-plant oil study, potentially including lipid profile or protein levels across experimental groups.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 18
Figure 18 Chart

Inflammatory marker levels or immunological parameters measured in rats exposed to diazinon with and without plant oil protection.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 19
Figure 19 Chart

Dose-response or time-course data for plant oil protective effects against diazinon-induced hepatorenal toxicity in the rat model.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 20
Figure 20 Chart

Summary comparison of hepatoprotective efficacy across the different plant oils tested in the diazinon toxicity study.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 21
Figure 21 Chart

Summary comparison of nephroprotective efficacy across the different plant oils evaluated against diazinon-induced renal damage.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 22
Figure 22 Chart

Supplementary biochemical or histological data from the plant oil-diazinon study, providing additional evidence for the protective mechanisms.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 23
Figure 23 Chart

Final summary data from the hepatorenal toxicity study, consolidating the evidence for plant oil protection against diazinon-induced organ damage in rats.

Protective effect of some plant oils on diazinon induced hepatorenal toxicity in …

Figure 2 Examples of PBM devices for alopecia. (A) HairMax LaserComb (Lexington Int, Boca Raton, FL); (B) HairMax LaserBand 82 (Lexington); (C) RedRestore Max Laser Cap 272 (Capillus, Miami, FL); (D) Revage 670 Laser Hood (Apira Science, Boca Raton, FL).
Figure 5 Photograph

Examples of commercially available photobiomodulation devices for alopecia treatment, including the HairMax LaserComb, LaserBand, and various laser cap models from different manufacturers.

Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and …

Fig 1. Hair regrowth in ophiasis-type alopecia areata after platelet-rich plasma (PRP) injection. Occipital hair loss before treatment (A) and occipital hair regrowth 3 months after administration of PRP at a concentration 3.5 times above baseline (B).
Figure 1 Photograph

Clinical photographs showing hair regrowth in a patient with corticosteroid-resistant ophiasis-type alopecia areata before and 3 months after platelet-rich plasma (PRP) injection, with occipital hair loss markedly improved.

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP).

Figure 1
Figure 1

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 2
Figure 2

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 3
Figure 3

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 4
Figure 4

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 5
Figure 5

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 6
Figure 6

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 7
Figure 7

Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis.

Figure 1
Figure 1

Alopecia and platelet-derived therapies.

Figure 2
Figure 2

Alopecia and platelet-derived therapies.

Figure 3 Location of the PL, AA-PRP, and saline treatment zones for Subject C. Forty grafts were placed in each box, and hair checks were conducted 14 weeks post-surgery. PL, platelet lysate; AA– PRP, autologous activated platelet rich plasma.
Figure 3

Figure 3 Location of the PL, AA-PRP, and saline treatment zones for Subject C. Forty grafts were placed in each box, and hair checks were conducted 14 weeks post-surgery. PL, …

Alopecia and platelet-derived therapies.

Figure 4
Figure 4

Alopecia and platelet-derived therapies.

Figure 5
Figure 5

Alopecia and platelet-derived therapies.

Before
Figure 6

Before

Alopecia and platelet-derived therapies.

7ページ中4ページ目